Literature DB >> 21541081

A case of Noonan's syndrome with anomalous lymphorenal communication.

Sanjeeva Goli1, Vijay Kandimalla, Omar Khan.   

Abstract

Entities:  

Year:  2011        PMID: 21541081      PMCID: PMC3085967          DOI: 10.1258/shorts.2011.010102

Source DB:  PubMed          Journal:  JRSM Short Rep        ISSN: 2042-5333


× No keyword cloud information.
We report a case on a 12-year-old child with chyluria and Noonan's syndrome in whom lymphoscintigraphy demonstrated lymphatic communications within the urinary tract.

Case report

A 12-year-old boy with phenotypic characteristics of Noonan's syndrome who previously in 1997 underwent surgery for pulmonary stenosis, presented with a two-week history of passing ‘whitish-coloured urine’. This was biochemically and cytologically confirmed as chyluria but occasional red blood cells and mature reactive lymphocytes were also detected in the urine. From the age of 4 years he presented with intermittent short episodes of chyluria with spontaneous regression of symptoms following each episode. When his chyluria became protracted over a two-week period, however, he was referred for lymphoscintigraphy. 99mTc Sulphur colloid whole body lympho-scintigraphy was performed with 18.5 MBq administered subcutaneously in the first web space of both feet (Figure 1). Images were acquired in a 128 x 128 matrix with a Siemens orbiter 7500 gamma camera and a LEEP collimator. This demonstrated early visualization of the external and internal iliac lymph nodes and of both kidneys and ureters. At 25 min post injection the urinary bladder was also visualized.
Figure 1

Sequential images of bilateral lower limb 99m Tc Sulphur colloid lymphoscintingraphy obtained at 5-min intervals demonstrate visualization of inguinal lymph nodes at 10 min, activity within both kidneys at 15 min and bladder activity at 25 min

Sequential images of bilateral lower limb 99m Tc Sulphur colloid lymphoscintingraphy obtained at 5-min intervals demonstrate visualization of inguinal lymph nodes at 10 min, activity within both kidneys at 15 min and bladder activity at 25 min Ultrasound of the renal tract was reported as normal except for the observation of an undescended right testis which was identified in the inguinal region. Contrast-enhanced computerized tomography (CT) of the chest, abdomen and pelvis was also unremarkable except for the presence of multiple gallstones previously identified at sonography. An IVU performed for the exclusion of pyelo-ureteric stenosis,[1] a known association of Noonan's syndrome was also unremarkable.

Discussion

Chyluria is an abnormal condition in which chyle appears in the urine due to fistulous communication between the lymphatics and the urinary tract. Although several lymphatic and urinary tract abnormalities have been reported in Noonan's syndrome,[2,3] there has been no report in the literature in which direct communication between these two systems have been described. Lymphoscintigraphy has an established role in providing important physiological and anatomical information relevant for diagnosis and management especially when surgical intervention is contemplated.[4] Although widely considered to provide less detailed morphologic analysis of the lymphatic system than contrast lymphography, lymphoscintigraphy has the capability of rapidly demonstrating abnormal lymphatic communications whenever these exist.[5] The non-visualization of abnormal iliac and retro peritoneal lymphatic vessels and nodes by CT and MRI and visualization of these by lymphoscintigraphy only in our study further establishes the important role of lymphoscintigraphy when lymphatico-urinary communication is suspected. When such communications exist, lymphangiography is reported to provide better morphologic details because tracer dilution within the blood stream and tracer uptake by the liver and spleen may occur during lymphoscintigraphy. Radioactivity within the kidneys and bladder may also sometimes be difficult to differentiate between free pertechnetate and rarely from lymphatic reflux.[6] Although the most common cause of chyluria worldwide is due to Wuchereria bancrofti, non-parasitic chyluria may also arise due to thoracic duct stricture or direct injury. The mechanism for communication between the urinary tract and the lymphatics in Noonan's syndrome is poorly understood although several anomalies of the lymphatic system have been reported in this condition. These include lymphoedema, pulmonary lymphagectasis, intestinal and testicular lymphangiectasis, cystic hygroma, chylothorax and lymphatic dysplasia of the lip.[3] Lymphatic dysplasia/hypoplasia has also been reported in 15–20% of patients with Noonan's syndrome.[7] This condition has been linked to mutations in PTPN11 encoding the protein tyrosine phosphatase SHP-2 in more than 50% of cases studied. It has been postulated that the pathogenesis of this syndrome may arise from SHP-2 activity but genetic heterogeneity has also been recorded.[8] Recognized radiological manifestations include: hypoplastic peripheral lymphatic vessels; hypoplastic lymph nodes; chylothorax and pulmonary lymphangiectasia.[9] When obstructive lymphatic changes are present collateral formation in the retroperitoneal, mediastinal and cervical lymphatics[3] has been observed. Urinary tract abnormalities including obstructive uropathy secondary to pyeloureteral stenosis duplication of the collecting system, renal hypoplasia and polycystic renal disease have also been described in Noonan's syndrome. An IVU and micutrating cystography performed to exclude urinary tract anomalies and vesico ureteric reflux were both normal in our study. Although not considered to be life-threatening, at least 50% of cases of chyluria are reported to resolve spontaneously.[10] Recognized methods of treatment include sclerotherapy[10] somatostation therapy[11] and lymphatic microsurgery, but none of these management protocols were employed as the patient's chyluria spontaneously resolved over a one-month period following presentation. The principal aim when surgery is contemplated is to identify the site of lymphatic obstruction and to detect any co-existing lymphatic collaterals and to preserve the latter.[12] Although lymphangiography is the ‘gold’ standard for the visualization of the lymphatic system the technique requires expertise for cannulation and significant radiation exposure can result.[13] As accurate anatomical detail is often not provided by lymphoscintigraphy, lymphangiography may be considered if surgery is contemplated.[14] We did not attempt lymphangiography in this patient, as the specified equipment required for the procedure does not exist at our institution. In recent years lymphoscintigraphy has essentially replaced lymphangiography. In most clinical situations lymphoscintigraphy has been reported to provide adequate and even additional information in the evaluation of congenital lymphatic abnormalities. It is less time-consuming, non-invasive, reproducible and is associated with less radiation exposure compared to lymphangiography. This case provides supportive evidence for its clinical utilization when chyluria is suspected, as it was able to readily demonstrate 99mTc labeled colloid within iliac nodes and thereafter within the kidneys and urinary bladder.

DECLARATIONS

Competing interests

None declared

Funding

None

Ethical approval

Written consent to publication has been obtained from the patient or next of kin

Guarantor

SG

Contributorship

All authors contributed equally

Acknowledgements

The authors thank Leonardo Akan, consultant paediatrician at the Eric Williams Medical Complex for permission to publish this case

Reviewer

Donald Stanley
  10 in total

1.  A case of Noonan syndrome with pulmonary and abdominal lymphangiectasia.

Authors:  S Oztürk; K Cefle; S Palanduz; N B Erten; M A Karan; C Tasçioglu; S Umman; O Falay; S Vatansever; K Güler; S Cantez
Journal:  Int J Clin Pract       Date:  2000-05       Impact factor: 2.503

2.  Usefulness of lymphoscintigraphy in demonstrating lymphedema in patients with Noonan syndrome.

Authors:  Mei-Fang Cheng; Yen-Wen Wu; Kai-Yuan Tzen; Ruoh-Fang Yen
Journal:  Clin Nucl Med       Date:  2008-03       Impact factor: 7.794

3.  Spontaneous remission of chyluria.

Authors:  C Ohyama; H Saita; N Miyasato
Journal:  J Urol       Date:  1979-03       Impact factor: 7.450

4.  Case report: investigation of chyluria.

Authors:  M C Haddad; M S al Shahed; H S Sharif; U J Miola
Journal:  Clin Radiol       Date:  1994-02       Impact factor: 2.350

5.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.

Authors:  M Tartaglia; E L Mehler; R Goldberg; G Zampino; H G Brunner; H Kremer; I van der Burgt; A H Crosby; A Ion; S Jeffery; K Kalidas; M A Patton; R S Kucherlapati; B D Gelb
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

6.  [Radiological anomalies in the Noonan syndrome (author's transl)].

Authors:  J C Hoeffel; P Juncker; C Delgoffe; C Pernot
Journal:  Sem Hop       Date:  1982-05-06

7.  99mTc-Nannocolloid Localization of Lymphorenal Fistula Causing Chyluria.

Authors:  Maseeh Uz Zaman; Riffat Parveen Hussain; Khalil Ahmed Khan; Gufran Khan; M Nadeem Ahmad
Journal:  J Coll Physicians Surg Pak       Date:  2008-08       Impact factor: 0.711

8.  Lymphoscintigraphy and lymphangiography of lymphangiectasia.

Authors:  D Howarth; P Gloviczki
Journal:  J Nucl Med       Date:  1998-09       Impact factor: 10.057

9.  Lymphoscintigraphy in chyluria, chyloperitoneum and chylothorax.

Authors:  M H Pui; T C Yueh
Journal:  J Nucl Med       Date:  1998-07       Impact factor: 10.057

10.  Coughing may lead to spontaneous chylothorax and chylous ascites.

Authors:  Gokhan Adas; Oguzhan Karatepe; Muharrem Battal; Yasar Dogan; Savas Karyagar; Asim Kutlu
Journal:  Case Rep Gastroenterol       Date:  2007-12-31
  10 in total
  1 in total

1.  MR lymphangiography of lymphatic abnormalities in children and adults with Noonan syndrome.

Authors:  C C Pieper; J Wagenpfeil; A Henkel; S Geiger; T Köster; K Hoss; J A Luetkens; C Hart; U I Attenberger; A Müller
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.